HOME HEMO COMBI SET 03-2962-3

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-08-19 for HOME HEMO COMBI SET 03-2962-3 manufactured by Fresenius Medical Care North America.

Event Text Entries

[53460448] (b)(4) the plant investigation is in process. A supplemental mdr will be submitted upon completion of this activity.
Patient Sequence No: 1, Text Type: N, H10


[53460449] A home hemodialysis (hd) nurse reported to technical service a blood loss event that occurred during a patient's treatment. During the initial set-up, the patient's dialyzer became clotted. It is unknown if the patient was using heparin or not. The patient's blood was not returned and the entire circuit was discarded. The estimated blood loss (ebl) from this initial set-up was approximately 200ml. The machine was subsequently set-up with new supplies and the treatment was restarted. Shortly after restarting treatment, an alarm went off indicating there was air in the lines. (the patient was back in treatment at the time). The alarm could not be cleared and the technician supporting the call advised the nurse to restart the patient's treatment with new supplies (for a second time). Following the air detector alarm, and since there appeared to be no leaks or malfunctions, the majority of the patient's blood was returned. However, it was reported that there was red tinged saline in the venous drip chamber. Though minuscule, this information suggests there was blood loss from this second set-up. The disposable supplies from this set-up were also discarded. Ebl from the disposal of this circuit was approximately 50ml (at most). The patient was able to successfully complete treatment after restarting a second time (on the same machine). The patient's total ebl was approximately 250ml. No patient adverse effects were experienced and no medical intervention was required as a result of these reported events. The machine was reportedly functioning properly and alarmed appropriately. No machine repairs or calibrations were needed. The complaint devices were not available for evaluation as they were reportedly discarded.
Patient Sequence No: 1, Text Type: D, B5


[56040510] The complaint device was not returned for analysis; however, a case of companion samples from the distribution center were made available to the manufacturer for physical evaluation. A visual examination was performed on the tubing sets of the companion samples; no defects or irregularities were identified. The tubing sets were found to be visually acceptable. One (1) companion sample was then selected at random, and then tested using a 2008t hemodialysis machine for simulated use. The bloodline was able to be primed with no visible issues. During the simulated use test, fluid flowed through the lines without issue. There were no observations of a leak or air bubbles and no level variation of the venous or arterial drip chambers was visible to indicate the introduction of air into the blood circuit. The device worked as intended with no noted abnormalities and no defects identified. A records review was performed on the reported lot. An investigation of the device manufacturing records was conducted by the manufacturer. There were no deviations or non-conformances identified during the manufacturing process which could be associated with the reported event. In addition, the batch record review confirmed the labeling, material, and process controls were within specification. The lot passed all release criteria. The investigation into the cause of the reported problem was not able to confirm the failure mode. The reported defect of air pulled into lines was not able to be duplicated. Although the evaluation of the companion sample confirmed that the device functioned fully as designed and met specification, a definitive conclusion regarding the complaint incident cannot be reached without physical examination of the actual complaint device. Therefore, the complaint has been deemed unconfirmed.
Patient Sequence No: 1, Text Type: N, H10


[56040511] A case of companion samples from the reported lot was returned to the manufacturer for evaluation.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8030665-2016-00428
MDR Report Key5889375
Date Received2016-08-19
Date of Report2016-09-30
Date of Event2016-07-22
Date Mfgr Received2016-09-29
Device Manufacturer Date2016-02-04
Date Added to Maude2016-08-19
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. THOMAS JOHNSON
Manufacturer Street920 WINTER ST.
Manufacturer CityWALTHAM MA 02451
Manufacturer CountryUS
Manufacturer Postal02451
Manufacturer Phone7816999000
Manufacturer G1ERIKA DE REYNOSA, S.A. DE C.V.
Manufacturer StreetMIKE ALLEN #1331 PARQUE INDUSTRIAL REYNOSA
Manufacturer CityREYNOSA, TAMAULIPAS CP 88780
Manufacturer CountryMX
Manufacturer Postal Code88780
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameHOME HEMO COMBI SET
Generic NameHIGH PERMEABILITY HEMODIALYSIS SYSTEM FOR AT HOME USE
Product CodeONW
Date Received2016-08-19
Returned To Mfg2016-08-22
Catalog Number03-2962-3
Lot Number16BR01134
ID Number00840861100330
Device Expiration Date2019-02-28
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerFRESENIUS MEDICAL CARE NORTH AMERICA
Manufacturer AddressMIKE ALLEN #1331 PARQUE INDUSTRIAL REYNOSA REYNOSA, TAMAULIPAS CP 88780 MX 88780


Patients

Patient NumberTreatmentOutcomeDate
10 2016-08-19

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.